Concepedia

Christopher Dextras

CD

Statistics

Publications

7

Citations

256

H-Index

7

Active since

2012

Affiliations

National Cancer Institute(Current)

National Center for Advancing Translational Sciences

National Institutes of Health

Center for Cancer Research

University of Kansas

Christopher Dextras is an author at National Cancer Institute specializing in medicine, oncology, and pharmacology.

ORCID

Publications per year

2012–2022

7

Publications

7

Fluorescence endoscopic detection of murine colitis-associated colon cancer by topically applied enzymatically rapid-activatable probe

Makoto Mitsunaga, Nobuyuki Kosaka, Peter L. Choyke et al. · Gut · 2012 · 102 citations · Full text

, , +17

Metarrestin, a perinucleolar compartment inhibitor, effectively suppresses metastasis

Kevin J. Frankowski, Chen Wang, Samarjit Patnaik et al. · Science Translational Medicine · 2018 · 74 citations · Full text

, , +16

Targeting of Noncanonical Wnt5a Signaling by AP-1 Blocker Dominant-Negative Jun When It Inhibits Skin Carcinogenesis

Mun-Il Kang, A Baker, Christopher Dextras et al. · Genes & Cancer · 2012 · 26 citations · Full text

, , +17

Discovery and Optimization of Pyrrolopyrimidine Derivatives as Selective Disruptors of the Perinucleolar Compartment, a Marker of Tumor Progression toward Metastasis

Kevin J. Frankowski, Samarjit Patnaik, Chen Wang et al. · Journal of Medicinal Chemistry · 2022 · 16 citations · Full text

, , +13

Pharmacokinetic evaluation of the PNC disassembler metarrestin in wild-type and Pdx1-Cre;LSL-KrasG12D/+;Tp53R172H/+ (KPC) mice, a genetically engineered model of pancreatic cancer

Tomas Vilimas, Amy Q. Wang, Samarjit Patnaik et al. · Cancer Chemotherapy and Pharmacology · 2018 · 14 citations · Full text

, , +17

1–5 of 7